Inner Mongolia Yili Industrial Group has patented a Bifidobacterium lactis BL-99 strain deposited in China General Microbiological Culture Collection Center. The strain enhances immunity, promotes growth of beneficial bacteria, increases antibody-producing cells, and can be used in foods for immunity enhancement and preventing osteoporosis. GlobalData’s report on Inner Mongolia Yili Industrial Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Inner Mongolia Yili Industrial Group, Lactobacilli-based drug compositions was a key innovation area identified from patents. Inner Mongolia Yili Industrial Group's grant share as of February 2024 was 53%. Grant share is based on the ratio of number of grants to total number of patents.
Immunity-enhancing bifidobacterium lactis bl-99 strain
A recently granted patent (Publication Number: US11911423B2) discloses a method for enhancing the immune activity of the body by administering a specific strain of Bifidobacterium lactis, known as BL-99, to individuals in need of immune support. The strain, with a deposit number of CGMCC No. 15650, is administered in an effective amount to achieve the desired immune-boosting effects. The method involves various parameters to ensure the efficacy of the strain, including the form of administration, survival rates of viable bacteria in gastric acid, and specific immune markers such as carbon clearance index, half hemolysis value, antibody-producing cell number, NK cell activity, and phagocytosis rate of macrophages.
Furthermore, the patent also covers a method for improving immune activity by administering a bacteria preparation of Bifidobacterium lactis, which includes the BL-99 strain with the same deposit number. The bacteria preparation can be in the form of solid bacteria powder or liquid bacteria preparation, either in viable or inactivated form. Similar to the previous method, enhancing immune activity in this approach involves increasing specific immune markers such as carbon clearance index, half hemolysis value, antibody-producing cell number, NK cell activity, and phagocytosis rate of macrophages. The patent highlights the potential of Bifidobacterium lactis BL-99 in modulating immune responses and improving overall immune function in individuals requiring immune support.
To know more about GlobalData’s detailed insights on Inner Mongolia Yili Industrial Group, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
